Literature DB >> 10026353

Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy.

M Mundhenke1, B Schwartzkopff, M Köstering, U Deska, R M Klein, B E Strauer.   

Abstract

OBJECTIVE: To determine whether increased plasma concentrations of endothelin-1 (ET-1) and big endothelin (BET) play a role in the regulation of coronary circulation in patients with idiopathic dilated cardiomyopathy (IDCM).
SETTING: Tertiary referral centre for cardiac diseases. PATIENTS: Fourteen patients (eight male/six female; mean (SD) age 59 (9) years) with IDCM (ejection fraction 36 (9)%) and five normotensive subjects (two male/three female; age 52 (7) years) serving as controls were studied.
METHODS: Functional status was classified according to New York Heart Association (NYHA) class. Endogenous ET-1 and BET plasma concentrations from the aorta and the coronary sinus were determined by radioimmunoassay. Coronary blood flow, using the inert chromatographic argon method, myocardial oxygen consumption, and coronary sinus oxygen content under basal conditions were determined.
RESULTS: In the aorta, mean (SD) concentrations of ET-1 (IDCM 0.76 (0.25) v controls 0.31 (0.06) fmol/ml; p = 0.002) and BET (IDCM 3.58 (1.06) v controls 2.11 (0.58) fmol/ml; p = 0.014) were increased in patients with IDCM. Aortic ET-1 concentrations correlated positively with NYHA class (r = 0. 731; p < 0.001), myocardial oxygen consumption (r = 0.749; p < 0. 001), and coronary blood flow (r = 0.645; p = 0.003), but inversely with coronary sinus oxygen content (r = -0.633; p = 0.004), which was significantly decreased in IDCM patients (IDCM 4.68 (1.05) v controls 6.70 (1.06) vol%; p = 0.003).
CONCLUSIONS: The coronary circulation in patients with IDCM is exposed to an increased endothelin load. ET-1 concentrations correlate with functional deterioration. A decrease of the coronary sinus content of oxygen suggests a mismatch between coronary blood flow and metabolic demand. Thus, ET-1 might be a marker of a disequilibrium between myocardial oxygen demand and coronary blood flow in IDCM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026353      PMCID: PMC1728961          DOI: 10.1136/hrt.81.3.278

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  35 in total

1.  Nitric oxide-endothelin-1 interaction in humans.

Authors:  G Ahlborg; J M Lundberg
Journal:  J Appl Physiol (1985)       Date:  1997-05

Review 2.  Endothelin: a new cardiovascular regulatory peptide.

Authors:  A Lerman; F L Hildebrand; K B Margulies; B O'Murchu; M A Perrella; D M Heublein; T R Schwab; J C Burnett
Journal:  Mayo Clin Proc       Date:  1990-11       Impact factor: 7.616

3.  Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria.

Authors:  T Ishikawa; M Yanagisawa; S Kimura; K Goto; T Masaki
Journal:  Am J Physiol       Date:  1988-10

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.

Authors:  F G Spinale; J D Walker; R Mukherjee; J P Iannini; A T Keever; K P Gallagher
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

Review 6.  Control of myocardial oxygen consumption: physiologic and clinical considerations.

Authors:  E Braunwald
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

7.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

8.  Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy.

Authors:  T De Marco; K Chatterjee; J L Rouleau; W W Parmley
Journal:  Am Heart J       Date:  1988-04       Impact factor: 4.749

9.  Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.

Authors:  A Franco-Cereceda
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

Review 10.  Assessing the coronary circulation in hypertension.

Authors:  B E Strauer; B Schwartzkopff; M Kelm
Journal:  J Hypertens       Date:  1998-09       Impact factor: 4.844

View more
  6 in total

1.  Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

Authors:  Dogan Erdogan; Hakan Gullu; Mustafa Caliskan; Ozgur Ciftci; Semra Baycan; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

2.  Muscle metaboreflex-induced coronary vasoconstriction limits ventricular contractility during dynamic exercise in heart failure.

Authors:  Matthew Coutsos; Javier A Sala-Mercado; Masashi Ichinose; Zhenhua Li; Elizabeth J Dawe; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

Review 3.  Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.

Authors:  Maurizio Galderisi; Arcangelo D'Errico
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.

Authors:  Ivan Dimitrijevic; Marie-Louise Edvinsson; Qingwen Chen; Malin Malmsjö; Per-Ola Kimblad; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2009-08-25       Impact factor: 2.298

5.  Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathways.

Authors:  David Nilsson; Lotta Gustafsson; Angelica Wackenfors; Bodil Gesslein; Lars Edvinsson; Per Paulsson; Richard Ingemansson; Malin Malmsjö
Journal:  BMC Cardiovasc Disord       Date:  2008-09-08       Impact factor: 2.298

Review 6.  Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms.

Authors:  Ming Guo; Yue Liu; Dazhuo Shi
Journal:  Biomed Res Int       Date:  2016-05-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.